Recap: The Association for Research in Vision and Ophthalmology takes Seattle
ARVO attendees took a deep dive into trends and explored the near future of vision science
ARVO 2024: Non-invasive testing could use tear film to screen for changes in Huntington Disease
The mutant huntingtin protein in tear fluid may have the potential to serve as an early marker of changes in Huntington disease
ARVO 2024: Trial design and increased accuracy of meibomian gland morphology measurements
At the 2024 ARVO meeting, Andrew D. Pucker, OD, PhD, presented a paper on measuring meibomian gland morphology
ARVO 2024: Mutation agnostic optogenetic programme demonstrates possible treatment for patients with severe retinal degeneration
Allen Ho, MD, presented on the 12-month results of an mutation agnostic optogenetic programme at the ARVO 2024 meeting
